Crohn’s Disease and Ulcerative Colitis: Differences, Symptoms, and Advances in Treatment

Inflammatory bowel diseases (IBD) are chronic conditions that affect the digestive system and can significantly impact quality of life. Dr. Esther Torres, professor emerita at the Medical Sciences Campus and specialist in inflammatory bowel diseases, explains that the two main conditions within this group are Crohn’s disease and ulcerative colitis.

“Crohn’s disease can affect any part of the gastrointestinal tract, and its inflammatory process extends through all layers of the intestinal wall. In contrast, ulcerative colitis is limited to the colon, and its inflammation is much more superficial,” Dr. Torres explains.

The primary differences between these two conditions lie in their location and the depth of inflammation. While Crohn’s disease may involve any area from the mouth to the anus and affect the full thickness of the bowel wall, ulcerative colitis is confined to the colon and primarily affects the mucosal lining.

Symptoms of Inflammatory Bowel Disease

Inflammatory bowel diseases most commonly appear between the ages of 15 and 35, with a second peak occurring later in life. However, these conditions are increasingly being diagnosed in children and adolescents.

Common symptoms include urgency to have a bowel movement, a constant sensation of needing to evacuate (tenesmus), persistent diarrhea with blood and mucus, abdominal pain lasting weeks or months, weight loss, decreased appetite, and fatigue.

“Any of these symptoms is a warning sign. They are not normal and should prompt patients to seek evaluation by a specialist,” Dr. Torres emphasizes.

Treatment Options and Inflammation Control

Over the past two decades, treatment options for Crohn’s disease and ulcerative colitis have expanded significantly. All therapies are designed to control the inflammatory process mediated by the immune system.

For mild to moderate diseases, certain treatments act directly on the inflamed intestinal lining. In addition, biologic therapies and targeted treatments have been developed to block specific molecules involved in inflammation, offering greater effectiveness in moderate to severe cases.

Through Alivia Specialty Pharmacy (ASP), a line of business of Alivia Health, comprehensive support is available for patients requiring specialized therapies for inflammatory bowel disease. The ASP team coordinates specialty medications, assists with prior authorizations, provides treatment guidance, and ensures continuous follow-up to facilitate timely access to prescribed therapies.

Inflammatory bowel diseases present both physical and emotional challenges. However, with early diagnosis, appropriate treatment, and strong family and community support, patients can lead productive and fulfilling lives. Education and proper care make a meaningful difference.